# Sarepta Therapeutics, Inc.: Form 8-K, filed Jun 4, 2026

- Company: [Sarepta Therapeutics, Inc.](/companies/srpt.md) (CIK 873303)
- Form: 8-K
- Filed: 2026-06-04
- Accepted by EDGAR: Jun 4, 2026, 16:29 ET
- Period: 2026-06-04
- Accession: 0001193125-26-257501
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/873303/000119312526257501/d88936d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/873303/000119312526257501/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/873303/000119312526257501/d88936d8k.htm

Filed Jun 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-257501. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.